Dr. Lal PathLabs Limited Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited

LALPATHLAB

주식 순위 #4509
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
주가
$20.35
마지막 동기화: 2026-10-19
시가총액
$3.40B
변동 (1일)
-0.86%
변동 (1년)
13.63%
국가
IN
거래 Dr. Lal PathLabs Limited (LALPATHLAB)

카테고리

Healthcare
Dr. Lal PathLabs Limited (LALPATHLAB)의 P/B 비율
October 2026 기준 P/B 비율 TTM: 12.30
Dr. Lal PathLabs Limited의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 12.30입니다. 2024년 말 기준 P/B 비율은 10.30였습니다.
Dr. Lal PathLabs Limited의 P/B 비율 기록 (2011 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
2026 (TTM) 12.30 33.57%
2025 9.21 -10.56%
2024 10.30 13.24%
2023 9.09 -36.47%
2022 14.31 -20.24%
2021 17.95 60.49%
2020 11.18 22.31%
2019 9.14 1.33%
2018 9.02 -24.30%
2017 11.92 -20.38%
2016 14.97 14.51%
2015 13.07 -55.61%
2014 29.45 -29.99%
2013 42.07 -28.44%
2012 58.79 -19.94%
2011 73.44 0.00%
유사 기업 또는 경쟁사의 P/B 비율
회사 P/B 비율 P/B 비율 차이 국가
4.7411 -61.46%
US
3.0143 -75.50%
US
31.051 152.42%
US
- -
CN
6.6641 -45.83%
US